Imai, R., Ikemura, S., & Jinta, T. (2021). Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers. Respirol Case Rep.
Chicago Style aipamenaImai, Ryosuke, Sumie Ikemura, and Torahiko Jinta. "Anti‐TIF1γ Antibody‐positive Dermatomyositis Associated With Durvalumab Administration in a Patient With Lung and Oesophageal Cancers." Respirol Case Rep 2021.
MLA aipamenaImai, Ryosuke, Sumie Ikemura, and Torahiko Jinta. "Anti‐TIF1γ Antibody‐positive Dermatomyositis Associated With Durvalumab Administration in a Patient With Lung and Oesophageal Cancers." Respirol Case Rep 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.